Publications & Patents

Publications

2021


2020

Journal Articles (Research)

2019

Journal Articles (Research)

2018

Journal Articles (Research)

2017

Journal Articles (Research)

2016

Journal Articles (Research)

2015

Journal Articles (Research)

2014

Journal Articles (Research)

2013

Journal Articles (Research)

2012

Journal Articles (Research)

2011

Journal Articles (Research)

2010

Journal Articles (Research)

Conference Articles (Research)

2009

Journal Articles (Research)

2008

Book Chapters (Research)

Journal Articles (Research)

2007

Journal Articles (Research)

2005

Journal Articles (Research)

2004

Journal Articles (Research)

Conference Articles (Research)

  • Falasca, M., and T. Maffucci. 2004. “Phosphatidylinositol-3-phosphate, a new crucial player in insulin signalling, is generated via a TC10-mediated phosphoinositide 3-kinase C2alpha activation.” In 40th Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Sep 5, 2004, Munich, GERMANY: SPRINGER.
  • Falasca, M. 2004. “INHIBITION OF THE PI 3-K/AKT PATHWAY BY INOSITOL PENTAKISPHOSPHATE RESULTS IN PROAPOPTOTIC AND ANTI-ANGIOGENIC EFFECTS IN VITRO AND IN VIVO.”: INT INST ANTICANCER RESEARCH.

2003

Journal Articles (Research)

2002

Journal Articles (Research)

2001

Journal Articles (Research)

Conference Articles (Research)

  • Innominato, P. F., M. A. Mariggio’, E. Piccolo, T. Maffucci, S. Iacobelli, and M. Falasca. 2001. “The mechanism involved in the regulation of PLC gamma 1 activity in cell migration.”: AMER ASSOC CANCER RESEARCH.

2000

Journal Articles (Research)

1998

Journal Articles (Research)

1997

Journal Articles (Research)

1996

Journal Articles (Research)

Conference Articles (Research)

  • Corda, D., and M. Falasca. 1996. “Glycerophosphoinositols as potential markers of ras-induced transformation and novel second messengers.”
  • Corda, D., and M. Falasca. 1996. “Glycerophosphoinositols as potential markers of ras-induced transformation and novel second messengers.” In Symposium on Lipid Metabolism and Function in Cancer – Significance of Magnetic Resonance Spectroscopy (MRS) Measurements in Relation to Biochemical Processes and Cellular Control, at the 5th International Conference of Anticancer Research, Oct 18, 1995, CORFU, GREECE: INT INST ANTICANCER RESEARCH.

1995

Journal Articles (Research)

1994

Journal Articles (Research)

1993

Journal Articles (Research)

  • Iacovelli, L., M. Falasca, S. Valitutti, D. D’Arcangelo, and D. Corda. 1993. “Glycerophosphoinositol 4-phosphate, a putative endogenous inhibitor of adenylylcyclase.” Journal of Biological Chemistry 268 (27): 20402-20407.

1992

Journal Articles (Research)

Conference Articles (Research)

1991

Journal Articles (Research)

Conference Articles (Research)

1990

Journal Articles (Research)

PATENTS

• Novel inositol phosphate derivatives. Marco Falasca, Andrew Michael Riley, Himali Yasmin Godage, Barry Victor Lloyd Potter. WO 2011064559 A3 2011

• PCT Int. Appl. (2018), WO 2018170553 A1 20180927; M. Massi, P. V. Simpson, M. Falasca: “Complexes and uses thereof”, describing the use of organometallic rhenium complexes as anticancer agents.

• PCT/AU2018/050941; P. Simpson, M. Massi, M. Falasca: “Synthetic derivatives of oleoyllysophosphatidylinositol (oleoyl-LPI) and uses thereof”, describing the use of synthetic analogues of oleyl-LPIas agonist for the GPR119 receptor.